Table 1 Baseline characteristics

Male sex, n (%)

19 (52.8%)

39 (53.4%)

0.949

Age, years (mean ± SD)

74.31 ± 8.21

71.82 ± 6.82

0.104

Hypertension, n (%)

31 (86.1%)

59 (80.8%)

0.494

Diabetes mellitus, n (%)

20 (55.6%)

19 (26.0%)

0.003

Congenital heart disease, n(%)

1 (2.8%)

2 (2.7%)

1.000

Previous TIA/stroke, n (%)

12 (33.3%)

24 (32.9%)

0.962

Previous major bleeding, n (%)

4 (11.1%)

19 (26.0%)

0.073

Previous cardiac thrombus, n (%)

0 (0%)

6 (8.2%)

0.077

LAD, mm (mean ± SD)

46.53 ± 5.93

44.73 ± 5.53

0.197

LVEDd, mm (mean ± SD)

47.64 ± 5.16

46.79 ± 5.77

0.297

LVEF, % (mean ± SD)

61.75 ± 7.20

61.63 ± 7.37

0.856

CHA₂DS₂-VASc score (mean ± SD)

5.44 ± 1.85

4.22 ± 1.64

0.002

HAS-BLED score (mean ± SD)

3.39 ± 0.93

2.74 ± 1.05

0.003

Blood stasis in LAA, n (%)

0 (0%)

1 (1.4%)

1.000

Atrial fibrillation pattern

Recent-onset

8 (22.2%)

13 (17.8%)

0.583

Paroxysmal, n (%)

14 (38.9%)

24 (32.9%)

0.536

Persistent or permanent, n (%)

22 (61.1%)

49(67.1%)

0.536

Last PCI and LAAC interval time

-

-

<7 days

2 (5.5%)

7days-3months

4 (11.1%)

3months-12months

6 (16.7%)

>12months

24 (66.7%)